Berlin Beckons

Article

Join OTE in booth BL10 at this year's ESCRS congress

The largest European congress of the year is upon us again and it only seems like yesterday when the OTE team was dashing around the Stockholm International Fairs and Congress Center, to deliver all of the breaking news and announcements from last year's congress of the European Society of Cataract & Refractive Surgeons (ESCRS). This year's meeting will be taking place in Berlin; a city that we had the pleasure of visiting recently for the European Glaucoma Society (EGS) congress. During that time, we had the enviable task of sampling some of the culinary delights that the city had to offer. Naturally, this was all in the name of research. With this knowledge, together with the expertise of the Berlin Tourist Board, OTE has compiled a guide to help you make the most out of your stay in Berlin this September. Whether your interests lie in museums and historical architecture or you simply want to find a great place to stop by for a meal or a beer during your free time, OTE's seeingBerlin guide has something for everyone. Please either stop by the OTE booth (Bridge Lobby, BL10) during the meeting or, alternatively, go to http://www.oteurope.com/seeingberlin to receive your free copy of the seeingBerlin guide.

Once again, the team and I will be reporting live from the show each and every day; delivering breaking news from the podium and the show floor, podcasts, daily round-ups, interviews and a "pick of the day", as recommended by OTE's Editorial Advisory Board. To sign up to receive this free service, please go to http://www.oteurope.com/escrs08

Sticking with the theme of latest trends in cataract & refractive surgery, in this issue of OTE, I am delighted to deliver a comprehensive feature on microincision cataract surgery (MICS). Specifically, we reveal how many European surgeons have so far been convinced by the hype surrounding this technique, particularly in light of recent technological advances. This special feature includes expert opinions, product catalogues and statistics on the number of current and predicted users of the technique - basically, everything you need to know about the latest trends in cataract surgery.

Best wishes,

Fedra PavlouEditorfpavlou@advanstar.com

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
© 2025 MJH Life Sciences

All rights reserved.